ghk-cu subcutaneous injection study human injectable dosage ghk-cu typical dose subcutaneous Frontiers The potential of GHK as
Description
Not marketing claims
Early human data shows that kisspeptin receptor agonists can extend the duration of LH and FSH elevation compared to native kisspeptin, with potential for ovulation induction in anovulatory PMOS patients
This positions AOD 9064 as a multi-functional peptide with relevance beyond weight management, extending into musculoskeletal recovery protocols
Japjec M, Horvat Pavlov K, Petrovic A, et al
Low risk, minimal downtime and more affordable than surgery
This page is general education, not medical advice or a treatment plan
